The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: a prospective study

OBJECTIVE: The prognostic value of body mass index (BMI) in metastatic breast cancer (MBC) has not been fully elucidated. In a prospective study to investigate the chemo-sensitizing effect of statins on clinical outcomes in MBC patients who were scheduled to receive palliative chemotherapy (Carbopla...

Descripción completa

Detalles Bibliográficos
Autores principales: Alarfi, Hiba, Salamoon, Maher, Kadri, Mohammad, Alammar, Moosheer, Haykal, Mhd Adel, Alseoudi, Alhadi, Youssef, Lama A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667491/
https://www.ncbi.nlm.nih.gov/pubmed/29096707
http://dx.doi.org/10.1186/s13104-017-2876-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667491/
https://www.ncbi.nlm.nih.gov/pubmed/29096707
http://dx.doi.org/10.1186/s13104-017-2876-2

Ejemplares similares